
Citation: Nily Dan. Lipid-Nucleic Acid Supramolecular Complexes: Lipoplex Structure and the Kinetics of Formation[J]. AIMS Biophysics, 2015, 2(2): 163-183. doi: 10.3934/biophy.2015.2.163
[1] | Aaron C Shang, Kristen E Galow, Gary G Galow . Regional forecasting of COVID-19 caseload by non-parametric regression: a VAR epidemiological model. AIMS Public Health, 2021, 8(1): 124-136. doi: 10.3934/publichealth.2021010 |
[2] | Julia Metelka, Colin Robertson, Craig Stephen . Japanese Encephalitis: Estimating Future Trends in Asia. AIMS Public Health, 2015, 2(4): 601-615. doi: 10.3934/publichealth.2015.4.601 |
[3] | Mathieu Philibert, Mark Daniel . Predictors of Residential Mobility among Older Canadians and Impact on Analyses of Place and Health Relationships. AIMS Public Health, 2015, 2(1): 115-131. doi: 10.3934/publichealth.2015.1.115 |
[4] | Diane Hindmarsh, David Steel . Creating local estimates from a population health survey: practical application of small area estimation methods. AIMS Public Health, 2020, 7(2): 403-424. doi: 10.3934/publichealth.2020034 |
[5] | Helga Hallgrimsdottir, Leah Shumka, Catherine Althaus, Cecilia Benoit . Fear, Risk, and the Responsible Choice: Risk Narratives and Lowering the Rate of Caesarean Sections in High-income Countries. AIMS Public Health, 2017, 4(6): 615-632. doi: 10.3934/publichealth.2017.6.615 |
[6] | Okan Bulut, Cheryl N. Poth . Rapid assessment of communication consistency: sentiment analysis of public health briefings during the COVID-19 pandemic. AIMS Public Health, 2022, 9(2): 293-306. doi: 10.3934/publichealth.2022020 |
[7] | Rosemary Mamka Anyona, Maximilian de Courten . An Analysis of the Policy Environment Surrounding Noncommunicable Diseases Risk Factor Surveillance in Kenya. AIMS Public Health, 2014, 1(4): 256-274. doi: 10.3934/publichealth.2014.4.256 |
[8] | Margo Barr, Raymond Ferguson, Jason van Ritten, Phil Hughes, David Steel . Summary of the Impact of the Inclusion of Mobile Phone Numbers into the NSW Population Health Survey in 2012. AIMS Public Health, 2015, 2(2): 210-217. doi: 10.3934/publichealth.2015.2.210 |
[9] | Gareth Morgan . Does Utilitarian Policy such as Smoking Cessation Lend Support to Wider Aspirin Use?. AIMS Public Health, 2015, 2(2): 223-226. doi: 10.3934/publichealth.2015.2.223 |
[10] | Mehreen Tariq, Margaret Haworth-Brockman, Seyed M Moghadas . Ten years of Pan-InfORM: modelling research for public health in Canada. AIMS Public Health, 2021, 8(2): 265-274. doi: 10.3934/publichealth.2021020 |
Population estimates are of paramount importance in epidemiology since they represent denominators of occurrence measures and can be involved in calculation of risk rate ratios. For this reason, almost all high income countries in the world have developed national open-access databases that can be freely used by all scientists for obtaining population data stratified by gender, age and area level (state, region, province, city etc) [1]. In Europe these data are collected on an annual basis by the European Commission and include data on general population, live births and deaths occurred during the reference year and, usually, the total number of immigrated and emigrated subjects during the course of the year [2].
All these datasets are daily consulted by researchers for calculating incidence rates and prevalence of diseases as well as trends over time, comparing different areas or sub-populations with different demographic patterns.
In a large majority of studies that use public demographic data, scientists have to consider the role of data accuracy and completeness, since variations in these measures could lead to biased estimates and, consequently, to imprecise or erroneous epidemiological conclusions. In particular, in the last decades there has been an increasing interest in this active area of research with analysts trying to improve denominator estimates, evaluating the importance of this uncertainty and developing methods to handle the problem. In this sense, in Italy some criticisms in population registration process seem to be occurred in the years following the 2011 national Census [3]. There is the suspicion that largely fluctuating population sizes, when numerator (“cases of diseases”) is stable over time, could statistically significantly affect differences between occurrence rates.
According to these perplexities, by using data collected by the Italian National Institute of Statistics [4], this study has carried out a simulation of the impact of population size variability on incidence rates between couple of consecutive years with the same number of incident cases.
All data used in this study have been downloaded by the demo.istat web section of the ISTAT [5], that is an Italian public research organization producing official statistics in the service of citizens and policy-makers. In particular data from 1st January to 2002 to 1st January 2015 were considered with stratification by age, sex and Italian region of residency. These data are based on a continuous observation of the municipalities existing and considering the territorial evolution through time (birth and death of municipalities by aggregation, disaggregation, transfer from a province or region to another).
For years from 2002 to 2011 inter-censal resident population estimates, reconstructed backward by the ISTAT after the release of the Legal Population of Municipalities at the 2011 Population Census, were also used [5].
For the simulation analysis, years from 2011 to 2014 were considered. For each year (denoted as “index year”), expected cases were calculated at increasing arbitrarily fixed incidence rates (1/100,000; 10/100,000; 100/100,000 and 1,000/100,000), and the number of cases found in the “index year” (e.g. 2011) weas used as numerator for the “following year” (e.g. 2012), thus hypothesizing a constant number of cases between consecutive years. Arbitrarily fixed incidence of each “index year” was then compared with incidence in the “following year” in order to evaluate statistically significant differences, on a regional and national basis. For each comparison, relative risks (RRs) were calculated considering the “index year” as reference. P-value for testing the hypothesis that the true RR is equal to 1 and 95% confidence intervals were computed according to Mantel-Haenszel method proposed by Rothman and Greendland [6].
All calculations have been made by using R software version 3.5.2 [7].
Figure 1 depicts trends of annual Italian population from 2002 to 2018. For years 2002 to 2011 data included both inter-censal and reconstructed post-censal series. As shown, in 2011 data from Census reported 1,261,752 less residents than those calculated in inter-censal series (59,433,744 vs. 60,785,753, respectively). From 2013 to 2014 a significant increase in Italian population was recorded (from 59,685,227 in 2013 to 60,782,668 in 2014).
In Figure 2 the population percent change during a four year period (2011 to 2014) was reported for all Italian regions. In 2012 a decrease in population size was registered in all Italian regions (from −4.0% for Lazio to −0.73% for Trentino-Alto Adige) whereas in 2014 all regions recorded an increase in population size ranging from +5.6% (Lazio) to +0.38% (Basilicata).
In Table 1, trends of annual percentage changes stratified by age and sex have been reported. A particular decrease was evident in 2012, in both males and females, for 0–19 (−2.51% and −2.24%, respectively) and 20–39 (−5.22% and 4.33%, respectively) years old age groups. Otherwise subjects aged 80 years or more had a substantial increase in 2014 (+4.03% in males and +2.77% in females).
Males |
Females |
|||||||
2011 | 2012 | 2013 | 2014 | 2011 | 2012 | 2013 | 2014 | |
0–19 | 0.03% | −2.51% | 0.04% | 1.43% | 0.01% | −2.24% | −0.09% | 1.03% |
20–39 | −1.22% | −5.22% | −1.32% | 0.45% | −1.10% | −4.33% | −1.50% | −0.14% |
40–59 | 1.22% | −1.36% | 1.69% | 3.40% | 1.49% | −0.53% | 1.57% | 3.13% |
60–79 | 1.04% | −0.66% | 1.19% | 2.25% | 0.52% | −0.91% | 0.72% | 1.60% |
80–100 | 4.74% | 1.96% | 3.58% | 4.03% | 3.47% | 0.77% | 2.31% | 2.77% |
All age groups | 0.43% | −2.33% | 0.57% | 2.06% | 0.52% | −1.75% | 0.42% | 1.63% |
2012 vs. 2011 | 2013 vs. 2012 | 2014 vs. 2013 | |
Abruzzo | 1.0275d | 0.9954 | 0.9839 |
Aosta Valley | 1.0127 | 0.9904 | 0.9942 |
Apulia | 1.0102 | 0.9998 | 0.9904 |
Basilicata | 1.0172 | 1.0024 | 0.9962 |
Calabria | 1.0271d | 1.0001 | 0.9887 |
Campania | 1.0121d | 0.9991 | 0.9829d |
Emilia Romagna | 1.021d | 0.9917 | 0.9845d |
Friuli-Venezia Giulia | 1.0148 | 0.9967 | 0.9939 |
Lazio | 1.0416c,d | 0.9897 | 0.9467c,d |
Liguria | 1.0315d | 1.0014 | 0.9832 |
Lombardy | 1.0224d | 0.9904d | 0.9821d |
Marche | 1.016 | 0.9971 | 0.9949 |
Molise | 1.0212 | 0.9994 | 0.9956 |
Piedmont | 1.0229d | 0.9963 | 0.9859d |
Sardinia | 1.0229d | 0.9985 | 0.9859 |
Sicily | 1.0102 | 0.9999 | 0.9814d |
Tuscany | 1.0224d | 0.9932 | 0.9846d |
Trentino-Alto Adige | 1.0073 | 0.9900 | 0.9886 |
Umbria | 1.0263 | 0.9966 | 0.9883 |
Veneto | 1.0173d | 0.9942 | 0.9909 |
Italy | 1.0207c,d | 0.9951d | 0.9819c,d |
Note: Statistically significant difference with “index year” fixed at incidence rate: (a) 1/100,000; (b) 10/100,000; (c) 100/100,000 and (d) 1,000/100,000.
Table 2 summarizes comparisons between each couple of years (“index year” as reference). Statistically significant higher RRs (ranging from 1.012 and 1.0416) were found in 2012 vs. 2011 in Italy and in other 11 regions for “index year” incidence fixed at 1,000/100,000 cases per year and in Italy and Lazio for “index year” incidence fixed at 100/100,000 cases per year. In 2013 vs. 2012 Italy and Lazio showed statistically significant lower RRs for “index year” incidence rates fixed at 1,000/100,000 cases per year.
In 2014 vs. 2013 statistically significant lower RRs (ranging from 0.9467 and 0.9846) were found in Italy and in other 6 regions for “index year” incidence fixed at 1,000/100,000 cases per year and in Italy and Lazio for “index year” incidence fixed at 100/100,000 cases per year.
The present paper intended to evaluate a methodological aspect that seems to be commonly neglected during epidemiological investigations on general population including those carried out by cancer and mortality registries, epidemiological surveillance systems and health agency reports. The question under discussion is if population data, used as denominator in epidemiological studies, can represent a source of bias and how large can be the weight of this bias when present. Some authors suggest that errors in denominator terms can have a non-trivial impact on the results. In particular, in suburbanized areas population size can vary up to a 20%. When discrepancies of this magnitude occur an estimated incidence rate ratio can be 1.5 times the true ratio [8]. Other authors have estimated that over 10-year periods starting at the previous census, a substantial amount of error may accumulate ranging between as low as 10% and as high as 80% within any age/sex five-year age group [9],[10].
For investigating this issue, a simulation on Italian data collected by a national research organization (ISTAT) has been performed. The hypothesis was that a relatively large variation of population size between years with a constant number of cases could determine statistically significant differences in incidence rates. These differences are of great interest since they could represent the basis for implementing public health control strategies that could be avoided with unbiased population estimations. The simulation seems to confirm that significant differences due to population size could be found between years, both at a regional or national level, when investigating diseases with medium-high incidence rates (usually >100/100,000). This finding is quite expected since as the number of cases or events (numerator) and the study population (denominator) increase the relative width of the confidence interval becomes narrower [11]. In particular in 2012, the important decrease in population size at fixed number of cases determined a consequent increase in incidence rates with higher RRs, that were statistically significant at a national level and also in some regions. Otherwise in 2014 the increase in population size lowered incidence rates with protective RRs with respect to 2013.
It should be noted that the ISTAT have clarified that, between 2011 and 2014, the variability in population size could be at least in part attributable to some discrepancies between 2011 Census and Legal Population of Municipalities data. In this period, these discrepancies have determined 1,243,957 corrections (1,610,058 in plus and 366,101 in minus) of which about 85% was performed in 2013 [3].
In the pre-census period, some Italian authors have found that using inter-censal population as denominator for the year 2002–2011 produces a remarkable distortion of both temporal trend and geographical comparisons for cancer incidence rates, confirming some perplexities reported in this paper [12]. Some other authors have highlighted that particular race-specific estimates could prove far less reliable, with severe overestimates and underestimates of all racial groups in various counties nationwide [13].
Considering the reported problems in estimating population size and in absence of gold standard data, researchers should be encouraged to implement actions for reducing the risk of biased population denominators, especially for years where denominators are known to or have been declared to be fluctuating [14]–[17].
Ignoring the problem could be considered a possible solution when the numerator has a quit small incidence rates (<100/100,000 as we have simulated) or when variations in the size of the population are likely to be very small compared to the estimated effects. Otherwise, when one of the two previous situations is not satisfied, the international literature suggests several ways to try to take into account these problems. The first of these possibilities is to add to the statistical model a variable that allow the researchers to control for a proxy that is theoretically related to the size of the exposed population. A second possibility is to perform a mathematical estimation of the denominator by using some other data (for example interpolation by using other years data or moving means) or evaluating results by a sensitivity analysis [18] or other methods [19]. Finally, it can be also considered the possibility to deal with problem by study design as in the case of case-crossover design where population denominators are not used. More recently Jung et al have reported that, in some circumstances, new adjustment method dramatically enhances the statistical validity of global and local spatial autocorrelation statistics [20].
Of course, the present study has several limitations. First of all, it is a simulation and thus it could be not representative of events in the real life. As second point, demographic data could be more accurate than that assumed in this paper and thus, in this last case, calculated RRs would have estimated the true incidence rate ratios. Moreover, we have chosen to not add a further random noise to the numerator since our model considers that numerators (and, thus, the cases of diseases) are observed with a very high accuracy whereas when considering diseases with concerns of case-finding our model could be subjected to a type I error.
Finally, incidence rates were compared without adjustment for age and sex that could have an impact on estimates. In this sense, the large variability found in Italian population changes by age groups in different years seems to suggest that adjusted-rates could increase the statistical significant differences between estimates.
Despite these possible limits, this paper shows that in epidemiological studies the attention directed toward the ascertainment of accurate numerators can be not considered enough to warrant unbiased estimates when denominators are fluctuating and potentially inaccurate.
[1] |
Friedmann T, Roblin R (1972) Gene therapy for human genetic disease? Science (New York, NY) 175: 949-955. doi: 10.1126/science.175.4025.949
![]() |
[2] | Forsythe JA, Jiang BH, Iyer NV, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613. |
[3] |
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138. doi: 10.1038/nrd2742
![]() |
[4] |
Caplen NJ, Alton E, Middleton PG, et al. (1995) Liposome-mediated CFTR gene-transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1: 39-46. doi: 10.1038/nm0195-39
![]() |
[5] | Fujiwara T, Grimm EA, Mukhopadhyay T, et al. (1994) Induction of chemosensitivity in human lung cancer cells in-vivo by adenovirus-mediated transfer of the wild type P53 gene. Cancer Res 54: 2287-2291. |
[6] |
Merdan T, Kopecek J, Kissel T (2002) Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Delivery Rev 54: 715-758. doi: 10.1016/S0169-409X(02)00046-7
![]() |
[7] |
Abou-El-Enein M, Bauer G, Reinke P, et al. (2014) A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV. Trends Mol Med 20: 632-642. doi: 10.1016/j.molmed.2014.08.004
![]() |
[8] |
Carnio S, Novello S, Bironzo P, et al. (2014) Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer. Expert Review Anticancer Therapy 14: 1495-1513. doi: 10.1586/14737140.2014.949245
![]() |
[9] |
Pensado A, Seijo B, Sanchez A (2014) Current strategies for DNA therapy based on lipid nanocarriers. Expert Opinion Drug Delivery 11: 1721-1731. doi: 10.1517/17425247.2014.935337
![]() |
[10] |
Qasim W, Thrasher AJ (2014) Progress and prospects for engineered T cell therapies. Brit J Haematol 166: 818-829. doi: 10.1111/bjh.12981
![]() |
[11] |
Sahay G, Querbes W, Alabi C, et al. (2013) Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol 31: 653-U119. doi: 10.1038/nbt.2614
![]() |
[12] |
Schroeder A, Levins CG, Cortez C, et al. (2010) Lipid-based nanotherapeutics for siRNA delivery. J Intern Med 267: 9-21. doi: 10.1111/j.1365-2796.2009.02189.x
![]() |
[13] |
Xue W, Dahlman JE, Tammela T, et al. (2014) Small RNA combination therapy for lung cancer. P Natl Acad Sci U S A 111: E3553-E3561. doi: 10.1073/pnas.1412686111
![]() |
[14] |
Dahlman JE, Barnes C, Khan OF, et al. (2014) In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat Nanotechnol 9: 648-655. doi: 10.1038/nnano.2014.84
![]() |
[15] | Ramamoorth M, Narvekar A (2015) Non viral vectors in gene therapy- an overview. J Clinical Diagnostic Res JCDR 9: GE01-06. |
[16] |
Yang J, Liu H, Zhang X (2014) Design, preparation and application of nucleic acid delivery carriers. Biotechnology Advances 32: 804-817. doi: 10.1016/j.biotechadv.2013.11.004
![]() |
[17] |
Choi YS, Lee MY, David AE, et al. (2014) Nanoparticles for gene delivery: therapeutic and toxic effects. Molecular Cellular Toxicology 10: 1-8. doi: 10.1007/s13273-014-0001-3
![]() |
[18] |
Dan N, Danino D (2014) Structure and kinetics of lipid-nucleic acid complexes. Adv Colloid Interface 205: 230-239. doi: 10.1016/j.cis.2014.01.013
![]() |
[19] |
Li S, Huang L (2000) Nonviral gene therapy: promises and challenges. Gene Ther 7: 31-34. doi: 10.1038/sj.gt.3301110
![]() |
[20] |
Mintzer MA, Simanek EE (2009) Nonviral vectors for gene delivery. Chem Rev 109: 259-302. doi: 10.1021/cr800409e
![]() |
[21] | Schaffer DV, Fidelman NA, Dan N, et al. (2000) Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 67: 598-606. |
[22] |
Radler JO, Koltover I, Salditt T, et al. (1997) Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275: 810-814. doi: 10.1126/science.275.5301.810
![]() |
[23] | Koltover I, Salditt T, Radler JO, et al. (1998) An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281: 78-81. |
[24] |
Simberg D, Danino D, Talmon Y, et al. (2001) Phase behavior, DNA ordering, and size instability of cationic lipoplexes—Relevance to optimal transfection activity. J Biol Chem 276: 47453-47459. doi: 10.1074/jbc.M105588200
![]() |
[25] |
Evans HM, Ahmad A, Ewert K, et al. (2003) Structural polymorphism of DNA-dendrimer complexes. Phys Rev Lett 91: 075501. doi: 10.1103/PhysRevLett.91.075501
![]() |
[26] |
Merkel OM, Mintzer MA, Sitterberg J, et al. (2009) Triazine dendrimers as nonviral gene delivery systems: effects of molecular structure on biological activity. Bioconjug Chem 20: 1799-1806. doi: 10.1021/bc900243r
![]() |
[27] |
Juliano R, Alam MR, Dixit V, et al. (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 36: 4158-4171. doi: 10.1093/nar/gkn342
![]() |
[28] |
de Fougerolles A, Vornlocher HP, Maraganore J, et al. (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6: 443-453. doi: 10.1038/nrd2310
![]() |
[29] |
Akinc A, Goldberg M, Qin J, et al. (2009) Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther 17: 872-879. doi: 10.1038/mt.2009.36
![]() |
[30] |
Desigaux L, Sainlos M, Lambert O, et al. (2007) Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference. Proc Natl Acad Sci U S A 104: 16534-16539. doi: 10.1073/pnas.0707431104
![]() |
[31] |
Tros de Ilarduya C, Sun Y, Duzgunes N (2010) Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 40: 159-170. doi: 10.1016/j.ejps.2010.03.019
![]() |
[32] |
Ma BC, Zhang SB, Jiang HM, et al. (2007) Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Controlled Release 123: 184-194. doi: 10.1016/j.jconrel.2007.08.022
![]() |
[33] |
Kapoor M, Burgess DJ, Patil SD (2012) Physicochemical characterization techniques for lipid based delivery systems for siRNA. Int J Pharm 427: 35-57. doi: 10.1016/j.ijpharm.2011.09.032
![]() |
[34] |
Wasungu L, Hoekstra D (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116: 255-264. doi: 10.1016/j.jconrel.2006.06.024
![]() |
[35] |
Safinya CR, Ewert KK, Leal C (2011) Cationic liposome-nucleic acid complexes: liquid crystal phases with applications in gene therapy. Liq Cryst 38: 1715-1723. doi: 10.1080/02678292.2011.624364
![]() |
[36] |
May S, Ben-Shaul A (1997) DNA-lipid complexes: stability of honeycomb-like and spaghetti-like structures. Biophys J 73: 2427-2440. doi: 10.1016/S0006-3495(97)78271-7
![]() |
[37] |
Harries D, May S, Gelbart WM, et al. (1998) Structure, stability, and thermodynamics of lamellar DNA-lipid complexes. Biophys J 75: 159-173. doi: 10.1016/S0006-3495(98)77503-4
![]() |
[38] | Bruinsma R (1998) Electrostatics of DNA cationic lipid complexes: isoelectric instability. Eur Phys J B 4: 75-88. |
[39] |
Dan N (1996) Formation of ordered domains in membrane-bound DNA. Biophys J 71: 1267-1272. doi: 10.1016/S0006-3495(96)79326-8
![]() |
[40] |
Dan NL (1997) Multilamellar structures of DNA complexes with cationic liposomes. Biophys J 73: 1842-1846. doi: 10.1016/S0006-3495(97)78214-6
![]() |
[41] |
Dan N (1998) The structure of DNA complexes with cationic liposomes—cylindrical or flat bilayers? BBA-Biomembranes 1369: 34-38. doi: 10.1016/S0005-2736(97)00171-5
![]() |
[42] |
Simberg D, Danino D, Talmon Y, et al. (2001) Phase behavior, DNA ordering, and size instability of cationic lipoplexes—Relevance to optimal transfection activity. J Biol Chem 276: 47453-47459. doi: 10.1074/jbc.M105588200
![]() |
[43] | Simberg D, Danino D, Talmon Y, et al. (2003) Phase behavior, DNA ordering and size instability of cationic lipoplexes: Relevance to optimal transfection activity. J Liposome Res 13: 86-87. |
[44] |
Kastner E, Kaur R, Lowry D, et al. (2014) High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization. Int J Pharm 477: 361-368. doi: 10.1016/j.ijpharm.2014.10.030
![]() |
[45] |
Balbino TA, Azzoni AR, de la Torre LG (2013) Microfluidic devices for continuous production of pDNA/cationic liposome complexes for gene delivery and vaccine therapy. Colloid Surface B 111: 203-210. doi: 10.1016/j.colsurfb.2013.04.003
![]() |
[46] |
Chen D, Love KT, Chen Y, et al. (2012) Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation. J Am Chem Soc 134: 6948-6951. doi: 10.1021/ja301621z
![]() |
[47] |
Kennedy MT, Pozharski EV, Rakhmanova VA, et al. (2000) Factors governing the assembly of cationic phospholipid-DNA complexes. Biophys J 78: 1620-1633. doi: 10.1016/S0006-3495(00)76714-2
![]() |
[48] |
Pozharski EV, MacDonald RC (2007) Single lipoplex study of cationic lipoid-DNA, self-assembled complexes. Mol Pharm 4: 962-974. doi: 10.1021/mp700080m
![]() |
[49] |
Barreleiro PCA, Lindman B (2003) The kinetics of DNA-cationic vesicle complex formation. JPhys Chem B 107: 6208-6213. doi: 10.1021/jp0277107
![]() |
[50] |
Junquera E, Aicart E (2014) Cationic Lipids as Transfecting Agents of DNA in Gene Therapy. Current Topics Medicinal Chem 14: 649-663. doi: 10.2174/1568026614666140118203128
![]() |
[51] |
Ma B, Zhang S, Jiang H, et al. (2007) Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release 123: 184-194. doi: 10.1016/j.jconrel.2007.08.022
![]() |
[52] | Xiong F, Mi Z, Gu N (2011) Cationic liposomes as gene delivery system: transfection efficiency and new application. Pharmazie 66: 158-164. |
[53] |
Zhdanov RI, Podobed OV, Vlassov VV (2002) Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry 58: 53-64. doi: 10.1016/S1567-5394(02)00132-9
![]() |
[54] |
Cullis PR, de Kruijff B (1979) Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta 559: 399-420. doi: 10.1016/0304-4157(79)90012-1
![]() |
[55] |
Epand RM (1998) Lipid polymorphism and protein-lipid interactions. Biochim Biophys Acta 1376: 353-368. doi: 10.1016/S0304-4157(98)00015-X
![]() |
[56] |
Seddon JM (1990) STRUCTURE OF THE INVERTED HEXAGONAL (HII) PHASE, AND NON-LAMELLAR PHASE-TRANSITIONS OF LIPIDS. Biochim Biophys Acta 1031: 1-69. doi: 10.1016/0304-4157(90)90002-T
![]() |
[57] |
Netz RR, Andelman D (2003) Neutral and charged polymers at interfaces. Phys Rep 380: 1-95. doi: 10.1016/S0370-1573(03)00118-2
![]() |
[58] | Nelson P (2013) Biological Physics: Freeman. |
[59] |
Gregory J, Barany S (2011) Adsorption and flocculation by polymers and polymer mixtures. Adv Colloid Interface 169: 1-12. doi: 10.1016/j.cis.2011.06.004
![]() |
[60] | G. Fleer, M.A. Cohen Stuart, J.M.H.M. Scheutjens, et al. (1993) Polymers at Interfaces Springer;. |
[61] |
Sukhishvili SA, Granick S (1998) Polyelectrolyte adsorption onto an initially-bare solid surface of opposite electrical charge. J Chem Phys 109: 6861-6868. doi: 10.1063/1.477253
![]() |
[62] |
Pozharski E, MacDonald RC (2002) Thermodynamics of cationic lipid-DNA complex formation as studied by isothermal titration calorimetry. Biophys J 83: 556-565. doi: 10.1016/S0006-3495(02)75191-6
![]() |
[63] |
Pozharski E, MacDonald RC (2003) Lipoplex thermodynamics: Determination of DNA-cationic lipoid interaction energies. Biophys J 85: 3969-3978. doi: 10.1016/S0006-3495(03)74811-5
![]() |
[64] |
Koltover I, Salditt T, Safinya CR (1999) Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes. Biophys J 77: 915-924. doi: 10.1016/S0006-3495(99)76942-0
![]() |
[65] |
Ahsan A, Rudnick J, Bruinsma R (1998) Elasticity theory of the B-DNA to S-DNA transition. Biophys J 74: 132-137. doi: 10.1016/S0006-3495(98)77774-4
![]() |
[66] |
Hirsch-Lerner D, Barenholz Y (1999) Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry. Biochimica Et Biophysica Acta-Biomembranes 1461: 47-57. doi: 10.1016/S0005-2736(99)00145-5
![]() |
[67] |
Tilcock CP, Bally MB, Farren SB, et al. (1982) Influence of cholesterol on the structural preferences of dioleoylphosphatidylethanolamine-dioleoylphosphatidylcholine systems: a phosphorus-31 and deuterium nuclear magnetic resonance study. Biochemistry 21: 4596-4601. doi: 10.1021/bi00262a013
![]() |
[68] |
Danino D, Kesselman E, Saper G, et al. (2009) Osmotically induced reversible transitions in lipid-DNA mesophases. Biophys J 96: L43-45. doi: 10.1016/j.bpj.2008.12.3887
![]() |
[69] |
Scarzello M, Chupin V, Wagenaar A, et al. (2005) Polymorphism of pyridinium amphiphiles for gene delivery: influence of ionic strength, helper lipid content, and plasmid DNA complexation. Biophys J 88: 2104-2113. doi: 10.1529/biophysj.104.053983
![]() |
[70] |
Ewert KK, Evans HM, Zidovska A, et al. (2006) A columnar phase of dendritic lipid-based cationic liposome-DNA complexes for gene delivery: hexagonally ordered cylindrical micelles embedded in a DNA honeycomb lattice. J Am Chem Soc 128: 3998-4006. doi: 10.1021/ja055907h
![]() |
[71] |
Zidovska A, Evans HM, Ewert KK, et al. (2009) Liquid crystalline phases of dendritic lipid-DNA self-assemblies: lamellar, hexagonal, and DNA bundles. J Phys Chem B 113: 3694-3703. doi: 10.1021/jp806863z
![]() |
[72] | Wasungu L, Stuart MC, Scarzello M, et al. (2006) Lipoplexes formed from sugar-based gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes. Biochim Biophys Acta 1758: 1677-1684. |
[73] |
Bilalov A, Olsson U, Lindman B (2009) A cubic DNA-lipid complex. Soft Matter 5: 3827-3830. doi: 10.1039/b908939j
![]() |
[74] | Larsson K (1983) Two cubic phases in monoolein-water system. Nature. |
[75] |
Leal C, Ewert KK, Bouxsein NF, et al. (2013) Stacking of Short DNA Induces the Gyroid Cubic-to-Inverted Hexagonal Phase Transition in Lipid-DNA Complexes. Soft Matter 9: 795-804. doi: 10.1039/C2SM27018H
![]() |
[76] |
Farago O, Ewert K, Ahmad A, et al. (2008) Transitions between distinct compaction regimes in complexes of multivalent cationic lipids and DNA. Biophys J 95: 836-846. doi: 10.1529/biophysj.107.124669
![]() |
[77] |
Fire A, Xu S, Montgomery MK, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811. doi: 10.1038/35888
![]() |
[78] |
Davidson BL, Paulson HL (2004) Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol 3: 145-149. doi: 10.1016/S1474-4422(04)00678-7
![]() |
[79] | Ponnappa BC (2009) siRNA for inflammatory diseases. Curr Opin Investig Drugs 10: 418-424. |
[80] |
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138. doi: 10.1038/nrd2742
![]() |
[81] |
Takeshita F, Ochiya T (2006) Therapeutic potential of RNA interference against cancer. Cancer Sci 97: 689-696. doi: 10.1111/j.1349-7006.2006.00234.x
![]() |
[82] |
Leal C, Bouxsein NF, Ewert KK, et al. (2010) Highly efficient gene silencing activity of siRNA embedded in a nanostructured gyroid cubic lipid matrix. J Am Chem Soc 132: 16841-16847. doi: 10.1021/ja1059763
![]() |
[83] |
Leal C, Ewert KK, Shirazi RS, et al. (2011) Nanogyroids incorporating multivalent lipids: enhanced membrane charge density and pore forming ability for gene silencing. Langmuir 27: 7691-7697. doi: 10.1021/la200679x
![]() |
[84] |
Aytar BS, Muller JP, Kondo Y, et al. (2013) Redox-based control of the transformation and activation of siRNA complexes in extracellular environments using ferrocenyl lipids. J Am Chem Soc 135: 9111-9120. doi: 10.1021/ja403546b
![]() |
[85] |
Schroeder A, Levins CG, Cortez C, et al. (2010) Lipid-based nanotherapeutics for siRNA delivery. J Intern Med 267: 9-21. doi: 10.1111/j.1365-2796.2009.02189.x
![]() |
[86] |
Kim DH, Rossi JJ (2007) Strategies for silencing human disease using RNA interference. Nat Revs Genet 8: 173-184. doi: 10.1038/nrg2006
![]() |
[87] |
De Paula D, Bentley MV, Mahato RI (2007) Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA 13: 431-456. doi: 10.1261/rna.459807
![]() |
[88] | A.S. Edelstein, Cammarata RC (1996) Nanomaterials: Synthesis, Properties and Applications: Inst. of Physics Publishing. |
[89] |
Filippova NL (1998) Adsorption and desorption kinetics of polyelectrolytes on planar surfaces. Langmuir 14: 1162-1176. doi: 10.1021/la970544n
![]() |
[90] |
Iruthayaraj J, Poptoshev E, Vareikis AV, et al. (2005) Adsorption of low charge density polyelectrolyte containing poly(ethylene oxide) side chains on silica: Effects of ionic strength and pH. Macromolecules 38: 6152-6160. doi: 10.1021/ma050851x
![]() |
[91] |
Sedeva IG, Fornasiero D, Ralston J, et al. (2009) The Influence of Surface Hydrophobicity on Polyacrylamide Adsorption. Langmuir 25: 4514-4521. doi: 10.1021/la803838k
![]() |
[92] |
McFarlane A, Yeap KY, Bremmell K, et al. (2008) The influence of flocculant adsorption kinetics on the dewaterability of kaolinite and smectite clay mineral dispersions. Colloid Surface A 317: 39-48. doi: 10.1016/j.colsurfa.2007.09.045
![]() |
[93] |
Enarsson L-E, Wagberg L (2008) Adsorption kinetics of cationic polyelectrolytes studied with stagnation point adsorption reflectometry and quartz crystal microgravimetry. Langmuir 24: 7329-7337. doi: 10.1021/la800198e
![]() |
[94] |
van Heiningen JA, Hill RJ (2011) Polymer adsorption onto a micro-sphere from optical tweezers electrophoresis. Lab Chip 11: 152-162. doi: 10.1039/C005217P
![]() |
[95] |
Dickinson E, Eriksson L (1991) Particle flocculation by adsorbing polymers. Adv Colloid Interfac 34: 1-29. doi: 10.1016/0001-8686(91)80045-L
![]() |
[96] |
Barany S, Szepesszentgyorgyi A (2004) Flocculation of cellular suspensions by polyelectrolytes. Adv Colloid Interfac 111: 117-129. doi: 10.1016/j.cis.2004.07.003
![]() |
[97] |
Popa I, Gillies G, Papastavrou G, et al. (2009) Attractive Electrostatic Forces between Identical Colloidal Particles Induced by Adsorbed Polyelectrolytes. J Phys Chem B 113: 8458-8461. doi: 10.1021/jp904041k
![]() |
[98] |
Popa I, Gillies G, Papastavrou G, et al. (2010) Attractive and Repulsive Electrostatic Forces between Positively Charged Latex Particles in the Presence of Anionic Linear Polyelectrolytes. J Phys Chem B 114: 3170-3177. doi: 10.1021/jp911482a
![]() |
[99] |
Lin MY, Lindsay HM, Weitz DA, et al. (1989) Universality in colloid aggregation. Nature 339: 360-362. doi: 10.1038/339360a0
![]() |
[100] | S. Edelstein, Cammarata RC (1996) Nanomaterials: Synthesis, Properties and Applications: Inst. of Physics Publishing, London, UK. |
[101] |
Lai E, van Zanten JH (2002) Real time monitoring of lipoplex molar mass, size and density. J Control Release 82: 149-158. doi: 10.1016/S0168-3659(02)00104-9
![]() |
[102] |
Lai E, van Zanten JH (2001) Monitoring DNA/poly-L-lysine polyplex formation with time-resolved multiangle laser light scattering. Biophys J 80: 864-873. doi: 10.1016/S0006-3495(01)76065-1
![]() |
[103] |
Gershon H, Ghirlando R, Guttman SB, et al. (1993) Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry 32: 7143-7151. doi: 10.1021/bi00079a011
![]() |
[104] |
Zhang Y, Garzon-Rodriguez W, Manning MC, et al. (2003) The use of fluorescence resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during lipoplex formation. Biochim Biophys Acta 1614: 182-192. doi: 10.1016/S0005-2736(03)00177-9
![]() |
[105] |
Braun CS, Fisher MT, Tomalia DA, et al. (2005) A stopped-flow kinetic study of the assembly of nonviral gene delivery complexes. Biophys J 88: 4146-4158. doi: 10.1529/biophysj.104.055202
![]() |
[106] |
Barreleiro PC, May RP, Lindman B (2003) Mechanism of formation of DNA-cationic vesicle complexes. Faraday Discuss 122: 191-201; discussion 269-182. doi: 10.1039/b200796g
![]() |
[107] |
Leal C, Sandstrom D, Nevsten P, et al. (2008) Local and translational dynamics in DNA-lipid assemblies monitored by solid-state and diffusion NMR. BBA-Biomembranes 1778: 214-228. doi: 10.1016/j.bbamem.2007.09.035
![]() |
[108] |
Zuidam NJ, Barenholz Y (1997) Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin. Biochim Biophys Acta 1329: 211-222. doi: 10.1016/S0005-2736(97)00110-7
![]() |
[109] |
Zuidam NJ, Barenholz Y (1998) Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim Biophys Acta 1368: 115-128. doi: 10.1016/S0005-2736(97)00187-9
![]() |
[110] |
Szilagyi I, Trefalt G, Tiraferri A, et al. (2014) Polyelectrolyte adsorption, interparticle forces, and colloidal aggregation. Soft Matter 10: 2479-2502. doi: 10.1039/c3sm52132j
![]() |
[111] |
Maier B, Radler JO (1999) Conformation and self-diffusion of single DNA molecules confined to two dimensions. Phys Rev Lett 82: 1911-1914. doi: 10.1103/PhysRevLett.82.1911
![]() |
[112] |
Epand RF, Sarig H, Ohana D, et al. (2011) Physical properties affecting cochleate formation and morphology using antimicrobial oligo-acyl-lysyl peptide mimetics and mixtures mimicking the composition of bacterial membranes in the absence of divalent cations. J Phys Chem B 115: 2287-2293. doi: 10.1021/jp111242q
![]() |
[113] |
Epand RF, Mor A, Epand RM (2011) Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents. Cell Mol Life Sci 68: 2177-2188. doi: 10.1007/s00018-011-0711-9
![]() |
[114] |
Sarig H, Ohana D, Epand RF, et al. (2011) Functional studies of cochleate assemblies of an oligo-acyl-lysyl with lipid mixtures for combating bacterial multidrug resistance. FASEB J 25: 3336-3343. doi: 10.1096/fj.11-183764
![]() |
[115] |
Chen DL, Love KT, Chen Y, et al. (2012) Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation. J Am Chem Soc 134: 6948-6951. doi: 10.1021/ja301621z
![]() |
[116] |
Leung AKK, Hafez IM, Baoukina S, et al. (2012) Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core (vol 116, pg 18440, 2012). J Phys Chem C 116: 22104-22104. doi: 10.1021/jp3088786
![]() |
1. | Gabriel Camero, Guillermo Villamizar, Luis M. Pombo, Manuel Saba, Arthur L. Frank, Aníbal A. Teherán, Gerhard M. Acero, Epidemiology of Asbestosis between 2010–2014 and 2015–2019 Periods in Colombia: Descriptive Study, 2023, 89, 2214-9996, 10.5334/aogh.3963 | |
2. | Benoit Talbot, Antoinette Ludwig, Sheila F. O’Brien, Steven J. Drews, Nicholas H. Ogden, Manisha A. Kulkarni, Spatial and temporal analysis of West Nile virus infection in mosquito and human populations based on arboviral detection testing data, 2024, 14, 2045-2322, 10.1038/s41598-024-82739-3 | |
3. | Arnaud Tarantola, Mohamed Hamidouche, Use of cell phone data to correct Île-de-France population estimates and SARS-CoV-2 incidence, July to September, 2021: a proof-of-concept exercise, 2025, 30, 1560-7917, 10.2807/1560-7917.ES.2025.30.22.2400530 | |
4. | Yuya Ito, Takahiro Takazono, Hotaka Namie, Masato Tashiro, Hiroshi Kakeya, Yoshitsugu Miyazaki, Hiroshi Mukae, Hiroshige Mikamo, Tomoo Fukuda, Kazutoshi Shibuya, Koichi Izumikawa, Incidence of Coronavirus Disease 2019‐Associated Pulmonary Aspergillosis and Specialist Involvement in Its Diagnosis in Japan: A Nationwide Survey and Literature Review, 2025, 68, 0933-7407, 10.1111/myc.70077 |
Males |
Females |
|||||||
2011 | 2012 | 2013 | 2014 | 2011 | 2012 | 2013 | 2014 | |
0–19 | 0.03% | −2.51% | 0.04% | 1.43% | 0.01% | −2.24% | −0.09% | 1.03% |
20–39 | −1.22% | −5.22% | −1.32% | 0.45% | −1.10% | −4.33% | −1.50% | −0.14% |
40–59 | 1.22% | −1.36% | 1.69% | 3.40% | 1.49% | −0.53% | 1.57% | 3.13% |
60–79 | 1.04% | −0.66% | 1.19% | 2.25% | 0.52% | −0.91% | 0.72% | 1.60% |
80–100 | 4.74% | 1.96% | 3.58% | 4.03% | 3.47% | 0.77% | 2.31% | 2.77% |
All age groups | 0.43% | −2.33% | 0.57% | 2.06% | 0.52% | −1.75% | 0.42% | 1.63% |
2012 vs. 2011 | 2013 vs. 2012 | 2014 vs. 2013 | |
Abruzzo | 1.0275d | 0.9954 | 0.9839 |
Aosta Valley | 1.0127 | 0.9904 | 0.9942 |
Apulia | 1.0102 | 0.9998 | 0.9904 |
Basilicata | 1.0172 | 1.0024 | 0.9962 |
Calabria | 1.0271d | 1.0001 | 0.9887 |
Campania | 1.0121d | 0.9991 | 0.9829d |
Emilia Romagna | 1.021d | 0.9917 | 0.9845d |
Friuli-Venezia Giulia | 1.0148 | 0.9967 | 0.9939 |
Lazio | 1.0416c,d | 0.9897 | 0.9467c,d |
Liguria | 1.0315d | 1.0014 | 0.9832 |
Lombardy | 1.0224d | 0.9904d | 0.9821d |
Marche | 1.016 | 0.9971 | 0.9949 |
Molise | 1.0212 | 0.9994 | 0.9956 |
Piedmont | 1.0229d | 0.9963 | 0.9859d |
Sardinia | 1.0229d | 0.9985 | 0.9859 |
Sicily | 1.0102 | 0.9999 | 0.9814d |
Tuscany | 1.0224d | 0.9932 | 0.9846d |
Trentino-Alto Adige | 1.0073 | 0.9900 | 0.9886 |
Umbria | 1.0263 | 0.9966 | 0.9883 |
Veneto | 1.0173d | 0.9942 | 0.9909 |
Italy | 1.0207c,d | 0.9951d | 0.9819c,d |
Note: Statistically significant difference with “index year” fixed at incidence rate: (a) 1/100,000; (b) 10/100,000; (c) 100/100,000 and (d) 1,000/100,000.
Males |
Females |
|||||||
2011 | 2012 | 2013 | 2014 | 2011 | 2012 | 2013 | 2014 | |
0–19 | 0.03% | −2.51% | 0.04% | 1.43% | 0.01% | −2.24% | −0.09% | 1.03% |
20–39 | −1.22% | −5.22% | −1.32% | 0.45% | −1.10% | −4.33% | −1.50% | −0.14% |
40–59 | 1.22% | −1.36% | 1.69% | 3.40% | 1.49% | −0.53% | 1.57% | 3.13% |
60–79 | 1.04% | −0.66% | 1.19% | 2.25% | 0.52% | −0.91% | 0.72% | 1.60% |
80–100 | 4.74% | 1.96% | 3.58% | 4.03% | 3.47% | 0.77% | 2.31% | 2.77% |
All age groups | 0.43% | −2.33% | 0.57% | 2.06% | 0.52% | −1.75% | 0.42% | 1.63% |
2012 vs. 2011 | 2013 vs. 2012 | 2014 vs. 2013 | |
Abruzzo | 1.0275d | 0.9954 | 0.9839 |
Aosta Valley | 1.0127 | 0.9904 | 0.9942 |
Apulia | 1.0102 | 0.9998 | 0.9904 |
Basilicata | 1.0172 | 1.0024 | 0.9962 |
Calabria | 1.0271d | 1.0001 | 0.9887 |
Campania | 1.0121d | 0.9991 | 0.9829d |
Emilia Romagna | 1.021d | 0.9917 | 0.9845d |
Friuli-Venezia Giulia | 1.0148 | 0.9967 | 0.9939 |
Lazio | 1.0416c,d | 0.9897 | 0.9467c,d |
Liguria | 1.0315d | 1.0014 | 0.9832 |
Lombardy | 1.0224d | 0.9904d | 0.9821d |
Marche | 1.016 | 0.9971 | 0.9949 |
Molise | 1.0212 | 0.9994 | 0.9956 |
Piedmont | 1.0229d | 0.9963 | 0.9859d |
Sardinia | 1.0229d | 0.9985 | 0.9859 |
Sicily | 1.0102 | 0.9999 | 0.9814d |
Tuscany | 1.0224d | 0.9932 | 0.9846d |
Trentino-Alto Adige | 1.0073 | 0.9900 | 0.9886 |
Umbria | 1.0263 | 0.9966 | 0.9883 |
Veneto | 1.0173d | 0.9942 | 0.9909 |
Italy | 1.0207c,d | 0.9951d | 0.9819c,d |